A Pilot Study of [18F]F-AraG Pharmacokinetics in Tumors and Tissue Using Dynamic Total Body PET Imaging in Healthy Subjects and in Patients With Non-Small Cell Lung Cancer (NSCLC)

At a glance
Trial Overview
Trial Details
Interventions
Trial Centres
- Investigators
- Centres
Trial History
References

X

Trial Profile

A Pilot Study of [18F]F-AraG Pharmacokinetics in Tumors and Tissue Using Dynamic Total Body PET Imaging in Healthy Subjects and in Patients With Non-Small Cell Lung Cancer (NSCLC)

Status: Recruiting

Phase of Trial: Phase 0

Latest Information Update: 21 Aug 2024

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs 18F-F-AraG (Primary)
Indications Non-small cell lung cancer
Focus Pharmacokinetics

Most Recent Events

19 Aug 2024 Planned End Date changed from 1 Dec 2024 to 1 Dec 2026.
19 Aug 2024 Planned primary completion date changed from 1 Jun 2024 to 1 Jun 2025.
24 Jan 2024 Planned primary completion date changed from 1 Dec 2023 to 1 Jun 2024.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com